tyrphostin A9

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/2015 - "The clinical significance of this mechanism has already been highlighted by the finding that the kinase inhibitor tyrphostin A9 induces cancer cell death by DLP1-mediated mitochondrial fragmentation. " 05/13/2011 - "A receptor tyrosine kinase inhibitor, Tyrphostin A9 induces cancer cell death through Drp1 dependent mitochondria fragmentation."
2.	Neuroblastoma 05/13/2011 - "Moreover, treatment of Tyrphostin A9 also evoked mitochondrial fragmentation in other cells including the neuroblastomas. "
3.	Infections 11/01/2022 - "In addition, the time-of-addition assay indicated that Tyrphostin A9 worked in the stage of viral post-infection, and the UNC0638 in all pre-, co-, and post-infection stages. "
4.	Glioblastoma (Glioblastoma Multiforme) 07/01/2023 - "Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway."
5.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/01/2022 - "Tyrphostin A9 protects axons in experimental autoimmune encephalomyelitis through activation of ERKs."

1.	Small Interfering RNA (siRNA)
2.	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
3.	Tyrosine (L-Tyrosine)
4.	Proteins (Proteins, Gene)
5.	Phosphotransferases (Kinase)
6.	Tyrosine Kinase Inhibitors
7.	UNC 0638